BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Covington
McKesson
Mallinckrodt
QuintilesIMS
Citi
UBS
Queensland Health
Cerilliant
Accenture

Generated: January 24, 2018

DrugPatentWatch Database Preview

KLEBCIL Drug Profile

« Back to Dashboard

Which patents cover Klebcil, and when can generic versions of Klebcil launch?

Klebcil is a drug marketed by King Pharms and is included in one NDA.

The generic ingredient in KLEBCIL is kanamycin sulfate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the kanamycin sulfate profile page.
Drug patent expirations by year for KLEBCIL
Medical Subject Heading (MeSH) Categories for KLEBCIL

US Patents and Regulatory Information for KLEBCIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms KLEBCIL kanamycin sulfate INJECTABLE;INJECTION 062170-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
King Pharms KLEBCIL kanamycin sulfate INJECTABLE;INJECTION 062170-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
King Pharms KLEBCIL kanamycin sulfate INJECTABLE;INJECTION 062170-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Express Scripts
UBS
Argus Health
Fish and Richardson
Chubb
Mallinckrodt
Citi
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot